Hybrid fertility and reproductive care firm Kindbody scored a $25 million funding from JPMorgan Chase’s enterprise unit specializing in employer-sponsored healthcare, Morgan Well being.
Dr. Cheryl Pegus, managing director of Morgan Well being Ventures, will be a part of Kindbody’s board of administrators.
WHAT THEY DO
The New York-based firm affords digital and in-person providers, together with egg freezing, contraception care, gynecological care, fertility testing, and digital wellness and training providers.
Kindbody touts itself as a fertility advantages platform for 112 corporations, together with Walmart, Lyft and GEICO.
The funds will likely be used to scale the supply of its platform.
“The obstacles related to fertility make beginning or rising a household troublesome for tens of millions of People. Kindbody’s mission to offer a brand new fertility expertise with their very own healthcare professionals and advantages navigation is exclusive. Their deal with enhancing entry and well being outcomes helps mitigate most of the longstanding fairness challenges employers and workers face,” Dr. Pegus mentioned in an announcement. “I sit up for becoming a member of the Kindbody Board and dealing with the management group to satisfy the well being wants for the communities Kindbody serves.”
Simply two months in the past, Kindbody scored a whopping $100 million in funding.
In 2021, it raised $62 million in Collection C funding, which constructed on a $32 million Collection B increase from July 2020.
Final yr, the corporate made three acquisitions: genomics firm Phosphorus Labs, a community of fertility clinics referred to as the Vios Fertility Institute and Chicago-based surrogacy company Different Reproductive Sources.
Different corporations within the fertility area embrace fertility testing firm Proov, reproductive advantages supervisor Carrot Fertility and Nodal, a platform permitting surrogates to attach with supposed mother and father after reviewing their mum or dad profiles.